文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Effects of chitosan and water-soluble chitosan micro- and nanoparticles in obese rats fed
侵权投诉

Effects of chitosan and water-soluble chitosan micro- and nanoparticles in obese rats fed

International Journal of Nanomedicine

Open Access Full T

Effects of chitosan and water-soluble chitosan micro- and nanoparticles in obese rats fed

ext Article

Dovepress

open access to scientific and medical research

ORIGINAL RESEARCH

Effects of chitosan and water-soluble chitosan micro- and nanoparticles in obese rats fed a high-fat diet

This article was published in the following Dove Press journal: International Journal of Nanomedicine26 July 2012

Hong-liang Zhang1,2Xiao-bin Zhong1Yi Tao3

Si-hui Wu4

Zheng-quan Su2

Department of Pharmacy, First Affiliated Hospital of Guangxi Medical University, Nanning, 2Key Research Center of Liver Regulation for Hyperlipemia SATCM/Level 3 Laboratory of Lipid Metabolism, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, 3HEC

Pharm Group, Dongguan, 4Department of Pharmacy, Guangdong Food and Drug Vocational Technical School, Guangzhou, China

1

Purpose: This study determined the effects of chitosan (CTS) and water-soluble chitosan (WSC) microparticles (MPs) and nanoparticles (NPs) in rats with high-fat diet-induced obesity.

Methods: The rats were randomly separated into eight groups: a normal diet group (the blank control), a high-fat emulsion group (the negative control), CTS and WSC control groups, CTS-MP and WSC-MP groups, and CTS-NP and WSC-NP groups. All groups (except the blank control group) were fed the high-fat diet for 4 weeks to establish the obesity model. Different samples were administered orally once daily to the treatment groups for 4 weeks.

Results: A significantly lower weight gain was observed in the WSC-MP and WSC-NP groups, as well as in the CTS-MP and CTS-NP groups, compared with rats given a normal diet and a high-fat diet (P , 0.05). The WSC-MP rats had the least weight gain among all the groups. The food intake in the eight groups had the same trend as weight gain. CTS and WSC MPs and NPs significantly reduced the final amounts of epididymal and perirenal white adipose tissue. Liver weight was reduced in the CTS-MP group compared to rats fed a high-fat diet. Serum total cholesterol and low-density lipoprotein cholesterol were significantly reduced in all treatment groups, with the WSC-MP and CTS-MP groups showing a more significant reduction than the other groups. Triacylglycerol levels were significantly reduced in the WSC-NP group compared to the high-fat group. The mortality rates of CTS-MP, CTS-NP, WSC-MP, and WSC-NP groups were 30%, 30%, 55%, and 65%, respectively. The median lethal dose for the WSC-MP and WSC-NP groups were 4080 mg/kg and 2370 mg/kg, respectively.

Conclusion: These results indicate that CTS and WSC MPs and NPs have greater effects than commercially available CTS and WSC, and can be used as potential antiobesity agents.

Keywords: obesity, chitosan, water-soluble chitosan, microparticles, nanoparticles, acute toxicity

Introduction

Obesity is a growing problem that results in significant morbidity and mortality from weight-related disease and a reduced quality of life.1 Obese individuals are more likely to develop arthritis, lung disease, diabetes,2 metabolic syndrome, hypertension, and coronary artery disease,3 and are more likely to have a reduced lifespan.4

There is increasing interest in the use of natural resources as protective agents against obesity,5,6 because chemically synthetic compounds have some harmful side effects. Chitosan (CTS) is the N-deacetylated derivative of the polysaccharide chitin found in the shells of invertebrates such as shrimp and crabs.7 Due to its biocompatibil-ity and nontoxic nature, there is a growing interest in the potential of biologically active CTS. Water-soluble CTS (WSC) is a derivative of CTS. Because it is easily soluble

Correspondence: Zheng-quan Su Outside the Ring Road, No 280

Guangdong Pharmaceutical University, Guangzhou 510006, China Tel +86 20 3935 2067 Fax +86 20 3935 2065 Email suzhq@scnu.edu.cn

submit your manuscript | doc.guandang.net

Dovepress

doc.guandang.net

International Journal of Nanomedicine 2012:7 4069–40764069© 2012 Zhang et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email